帕马考昔是一流的 NSAID 候选药物,是碳酸酐酶 (CA) 和 COX-2 的双重抑制剂。它在小鼠模型中抑制大肠腺瘤和肿瘤生长。 Polmacoxib is a first-in-class NSAID drug candidate, is a dual inhibitor of carbonic anhydrase (CA) and COX-2. Polmacoxib inhibits premalignant and malignant colorectal lesions in mouse models, partly through inhibiting tumor cell proliferation.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
polmacoxib
CAS number:301692-76-2 molecular formula:C18H16FNO4S
overview
compound introduction
Specs
| Chinese alias | 4-(3-(3-氟苯基)-5,5-二甲基-4-氧代-4,5-二氢呋喃-2-基)苯磺酰胺 | 泊马昔布 | ||
| English alias | CG100649 | CG-100649 | CG 100649 | 4-[3-(3-fluorophenyl)-4,5-dihydro-5,5-dimethyl-4-oxo-2-furanyl]-benzenesulfonamide | ||
| CAS number | 301692-76-2 | molecular formula | C18H16FNO4S |
| molecular weight | 361.39 g/mol | Exact mass | - |
| PSA | 94.800 Ų | logp | 2.6 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





